During the past decade, Hospital El Tomillar conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital El Tomillar" are "Arthritis" (1 trials), "Osteoarthritis" (1 trials) and "Rhinitis or Rhinoconjunctivitis With or Without Asthma Induced by Hypersensitivity to Olea Europea Pollen" (1 trials). Many other conditions were trialed in "Hospital El Tomillar" in a lesser frequency.

Most popular intervention types in "Hospital El Tomillar" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Immunotherapy with modified extract of Olea europaea pollen" (1 trials), "NSAID" (1 trials), "Placebo" (1 trials) and "tanezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital El Tomillar" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hospital El Tomillar". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hospital El Tomillar, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital El Tomillar, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".